Early Treatment of ARNI on Myocardial Remodeling and Progress
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 280 participants.
Also called NCT04342351
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 280 participants
- Sponsor
- Registry
-
NCT04342351
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04342351. Randomized; double masking; primary purpose treatment. Start 2020-05-01 (anticipated); primary completion 2021-05-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Treatment of ARNI on Myocardial Remodeling and Progress
- Condition
- Myocardial Infarction
- Intervention (Drug)
- sacubitril/valsartan
- Intervention (Drug)
- perindopril
- Intervention (Other)
- Cardiopulmonary Exercise Test
- Intervention (Other)
- Echocardiogram
- Lead sponsor
- RenJi Hospital
Record details
- Record id
cardio:ct-nct04342351- Content hash
aac973a9282af4eecb23a4c5992fac9d494abcd889b8d0d7cb3993a370a5aa01